^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Vx-001

i
Other names: Vx-001, Vx001
Associations
Company:
Vaxon Biotech
Drug class:
Tumor-associated antigen inhibitor
Associations
over3years
Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC. (PubMed, Cancers (Basel))
These results support the hypothesis that Vx-001 may be efficient in patients with non-immunogenic/cold but not with immunogenic/hot tumors.
Clinical • Journal • Tumor Mutational Burden • PD(L)-1 Biomarker • IO biomarker
|
TMB (Tumor Mutational Burden) • CD8 (cluster of differentiation 8) • GZMB (Granzyme B)
|
PD-L1 expression
|
Vx-001